Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL244154 | 0.90 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL17776508 | 0.85 | — | — | |
| SCHEMBL24190367 | 0.77 | — | — | |
| SCHEMBL245584 | 0.77 | — | — | |
| SCHEMBL2744247 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL1570939 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL30457850 | 0.70 | — | — | |
| SCHEMBL6897985 | 0.63 | — | — | |
| SCHEMBL14968840 | 0.60 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL1929753 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240101516-A1 | SYNTHESIS OF POLYFLUORINATED ARYL AND HETEROARYL CARBOXAMIDES | BASF SE (DE) | 2024-03-28 | — | — | US | claimed |
| EP-4281436-A1 | SYNTHESIS OF POLYFLUORINATED ARYL AND HETEROARYL CARBOXAMIDES | BASF SE (DE) | 2023-11-29 | — | — | EP | claimed |
| EP-3419983-A1 | PROCESS FOR THE PREPARATION OF SOFOSBUVIR | HC-Pharma AG (CH) | 2019-01-02 | — | — | EP | claimed |
| WO-2017144423-A1 | PROCESS FOR THE PREPARATION OF SOFOSBUVIR | HC-PHARMA AG (CH) | 2017-08-31 | — | — | WO | claimed |
| EP-3180307-A1 | PROCESS FOR THE SYNTHESIS OF DAPSONE AND ITS INTERMEDIATES | Seegpharm SA (CH) | 2017-06-21 | — | — | EP | claimed |
| WO-2016077511-A1 | TWO-COMPONENT POLYURETHANE ADHESIVE COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-05-19 | — | — | WO | claimed |
| WO-2016016321-A1 | PROCESS FOR THE SYNTHESIS OF DAPSONE AND ITS INTERMEDIATES | SEEGPHARM SA (CH) | 2016-02-04 | — | — | WO | claimed |
| EP-1883641-A1 | PHTHALOCYANINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A (IT) | 2008-02-06 | — | — | EP | claimed |
| EP-1883640-A2 | PROCESS FOR PREPARING CHLORIDES OF PHTHALOCYANINE DERIVATIVES COMPRISING AT LEAST A QUATERNARY AMMONIUM GROUP | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO SOCIETA' PER AZIONI (IT) | 2008-02-06 | — | — | EP | claimed |
| WO-2006117399-A1 | PHTHALOCYANINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE | L. MOLTENI & C. DEI FRATELLI ALITTI - SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2006-11-09 | — | — | WO | claimed |
| WO-2006117396-A2 | PROCESS FOR PREPARING CHLORIDES OF PHTHALOCYANINE DERIVATIVES COMPRISING AT LEAST A QUATERNARY AMMONIUM GROUP | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2006-11-09 | — | — | WO | claimed |
| US-20240101516-A1 | SYNTHESIS OF POLYFLUORINATED ARYL AND HETEROARYL CARBOXAMIDES | BASF SE (DE) | 2024-03-28 | — | — | US | disclosed |
| EP-4281436-A1 | SYNTHESIS OF POLYFLUORINATED ARYL AND HETEROARYL CARBOXAMIDES | BASF SE (DE) | 2023-11-29 | — | — | EP | disclosed |
| EP-3419983-A1 | PROCESS FOR THE PREPARATION OF SOFOSBUVIR | HC-Pharma AG (CH) | 2019-01-02 | — | — | EP | disclosed |
| WO-2017144423-A1 | PROCESS FOR THE PREPARATION OF SOFOSBUVIR | HC-PHARMA AG (CH) | 2017-08-31 | — | — | WO | disclosed |
| WO-1997023469-A1 | PROCESS FOR THE PREPARATION OF 2-CHLORO-5-CHLOROMETHYL-THIAZOLE | NOVARTIS AG (CH) | 1997-07-03 | — | — | WO | disclosed |
| WO-1997020829-A1 | PROCESS FOR PREPARING 2-CHLOROTHIAZOLE COMPOUNDS | NOVARTIS AG (CH) | 1997-06-12 | — | — | WO | disclosed |
| WO-1997020809-A1 | PESTICIDES | NOVARTIS AG (CH) | 1997-06-12 | — | — | WO | disclosed |
| WO-1997020808-A1 | PROCESS FOR THE PREPARATION OF PESTICIDES | NOVARTIS AG (CH) | 1997-06-12 | — | — | WO | disclosed |
| WO-1997007103-A2 | PESTICIDAL INDAZOLE DERIVATIVES | NOVARTIS AG (CH) | 1997-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240101516-A1 | SYNTHESIS OF POLYFLUORINATED ARYL AND HETEROARYL CARBOXAMIDES | AADAC, PAICS, PARN | ALDH1A1 2089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.